1-6 of 6
Andrii Monastyrskyi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A060 Investigating underlying efficacy and mechanism of action of the KIF11 inhibitor filanesib in Ewing and clear cell sarcomas

Hannah L. Walker-Mimms, Nicole Londono, Yi Liao, Neelkamal Chaudhary, Mingxiang Teng, Fumi Kinose, Xueli Li, Andrii Monastyrskyi, Uwe Rix, Derek Duckett
Journal: Cancer Research
Cancer Res (2024) 84 (17_Supplement): A060.
https://doi.org/10.1158/1538-7445.PEDIATRIC24-A060
Published: 05 September 2024
View article titled, Abstract A060 Investigating underlying efficacy and mechanism of action of the KIF11 inhibitor filanesib in Ewing and clear cell sarcomas
Journal Articles

CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma

Karen L. Burger, Mario R. Fernandez, Mark B. Meads, Praneeth Sudalagunta, Paula S. Oliveira, Rafael Renatino Canevarolo, Raghunandan Reddy Alugubelli, Alexandre Tungsevik, Gabe De Avila, Maria Silva, Allison I. Graeter, Hongyue A. Dai, Nicole D. Vincelette, Antony Prabhu, Dario Magaletti, Chunying Yang, Weimin Li, Amit Kulkarni, Oliver Hampton, John M. Koomen, William R. Roush, Andrii Monastyrskyi, Anders E. Berglund, Ariosto S. Silva, John L. Cleveland, Kenneth H. Shain
Journal: Cancer Research
Cancer Res (2023) 83 (23): 3901–3919.
https://doi.org/10.1158/0008-5472.CAN-22-2350
Published: 01 December 2023
View article titled, CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma
Open the PDF for CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Abstract 3839: Discovery of GSTZ1 as a novel target for drug refractory non-small cell lung cancer by using fragment-based chemical proteomics

Yi Liao, Sean Chin Chan, Eric A. Welsh, Bin Fang, Luxin Sun, Ernst Schönbrunn, John M. Koomen, Derek R. Duckett, Eric B. Haura, Andrii Monastyrskyi, Uwe Rix
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3839.
https://doi.org/10.1158/1538-7445.AM2023-3839
Published: 04 April 2023
View article titled, Abstract 3839: Discovery of GSTZ1 as a novel target for drug refractory non-small cell lung cancer by using fragment-based chemical proteomics
Journal Articles

Abstract B028: CDK12/13 inhibition antagonizes resistance to KRASG12C inhibitors

Yaakov E. Stern, Pompom Ghosh, Hannah L. Walker-Mimms, John W. Mosior, Denis Imbody, Hitendra S. Solanki, Andrii Monastyrskyi, Derek R. Duckett, Eric B. Haura
Journal: Cancer Research
Cancer Res (2022) 82 (23_Supplement_2): B028.
https://doi.org/10.1158/1538-7445.CancEpi22-B028
Published: 01 December 2022
View article titled, Abstract B028: CDK12/13 inhibition antagonizes resistance to KRAS<sup>G12C</sup> inhibitors
Journal Articles

Abstract 3051: Targeting cdk12/13 re-sensitizes trastuzumab resistant her2+ breast cancers

Francesca Vena, Max Aceti, Simon Bayle, Victor Quereda, Andrii Monastyrskyi, William Roush, Derek Duckett
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3051.
https://doi.org/10.1158/1538-7445.AM2019-3051
Published: 01 July 2019
View article titled, Abstract 3051: Targeting cdk12/13 re-sensitizes trastuzumab resistant her2+ breast cancers
Journal Articles

Abstract 950: New strategy to sensitize pancreatic and bladder cancer to gemcitabine

Simon Bayle, Francesca Vena, Andrii Monastyrskyi, William Roush, Derek Duckett
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 950.
https://doi.org/10.1158/1538-7445.AM2018-950
Published: 01 July 2018
View article titled, Abstract 950: New strategy to sensitize pancreatic and bladder cancer to gemcitabine